Willkie Farr & Gallagher Competitors

Alan Assibey is a Chief Executive Officer at CADWALADER WICKERSHAM & TAFT and is based in Enfield, United Kingdom. He has worked as Finance Director at Movelle.

With more than 25 years of senior executive leadership roles in the health care industry that encompasses for-profit, non-profit acute care hospitals and community health center organizations. Steven provides visionary leadership to organizations emphasizing strategic planning, implementation of stretch goals and raising the bar to create centers of excellence. Professional Expertise: C-Suite Leadership and interim executive leadership, strategic planning, business development, fund development, organization development and start-ups, project management, board development, for-profit, non-profit operational management, board leadership and international hospital leadership.

PROFESSIONAL PROFILE: LEADERSHIP AND EXPERIENCEI have substantial experience in the HE sector at the highest levels of senior management both through my present appointment as Senior Vice-President (Global) and in my previous roles of Acting Deputy Vice-Chancellor (Research and Innovation) and Pro Vice-Chancellor (International relations) at the University of Surrey. Prior to joining Surrey in September 2012, during my tenure at UCL I was a significant contributor to the senior management team of the School of Life and Medical Sciences and Faculty of Biomedical Sciences and a major lead on quality assurance (in both teaching and learning and research) for the University. I also spearheaded our regional engagement programme through my role as a Pro-Provost. Most of my roles require, or have required, significant diplomatic skills and an ability to lead multidisciplinary complex teams in order to deliver the desired outcomes without the individuals necessarily being under my direct line management. Effective communication and ability to articulate a vision has been instrumental in achieving success together with effective use of networks of key individuals to deliver strategies . I am well versed in leading significant organisational change through engagement and persuasion. I regularly speak at Higher Education, research and International Summits in the UK and globally relating to research led teaching, building academic links with Asia, opportunities for educational development between the UK and other countries and university governance and management of strategic international developments. I sit or have sat on advisory boards for a range of Biotech and large Pharma companies including Roche, Novartis, MSD, Janssen, Johnsons and Johnson and also SMEs in the biotech sector. I have also undertaken medico-legal work as an advisor/witness for both defence and prosecution cases relating to organ transplantation and infectious diseases.

Mark Ruehlmann is a Chairman/CEO:Global at Squire Patton Boggs. He has worked as Partner at Squire Patton Boggs. Mark studied at Gamma Beta Phi Society, University Of Notre - Dam Do Lek, and University of Notre Dame.